https://www.statnews.com/2025/11/26/biotech-news-sarepta-duchenne-drug-cleared-to-test/
Sarepta Duchenne drug, Otsuka, Prasad, Medicare: The Readout
duchenne drugsareptaotsuka
https://www.biopharmadive.com/news/sarepta-duchenne-muscular-dystrophy-ppmo-results/599447/
Sarepta's second-gen Duchenne drug shows signs of topping its first | BioPharma Dive
second genduchenne drugshows
https://www.streetwisereports.com/article/2025/10/06/new-drug-for-duchenne-muscular-dystrophy-nears-potential-approval.html
New Drug for Duchenne Muscular Dystrophy Nears Potential Approval
Capricor Therapeutics Inc. (CAPR:NASDAQ) could receive a PDUFA date for its cell therapy as early as spring 2026 if it follows the FDA-outlined path forward,...
duchenne muscular dystrophy